Goldman Sachs Ups Target On Mead Johnson (MJN) Citing Increased M&A Probability
Tweet Send to a Friend
Goldman Sachs raised their price target on Mead Johnson Nutrition Company (NYSE: MJN) from $52 to ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
